Stay updated on Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.

Latest updates to the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page
- Check7 days agoChange DetectedThe page now lists 'Multiple myeloma' as a core topic and includes a 'related topics' entry for 'MedlinePlus Genetics', clarifying the study focus and linking to genetics resources.SummaryDifference0.1%

- Check14 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, representing a small version release.SummaryDifference0.0%

- Check21 days agoChange DetectedA new publication about infections in daratumumab-treated newly diagnosed multiple myeloma was added to the Publications list, and a previously listed infection-related article was removed, updating the study's bibliography.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.3, indicating a minor metadata-only update. There were no visible changes to the page content or user-facing features.SummaryDifference0.0%

- Check50 days agoChange DetectedA recruitment status note 'No longer looking for participants' was added to the study page. The page also gained new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a UI header change for Intervention/Treatment and an updated revision tag (from v3.5.5 to v3.6.0).SummaryDifference0.2%

- Check57 days agoChange DetectedA new page revision entry (v3.5.5) was added and the previous revision (v3.5.4) was removed, indicating a minor update to the page's documentation.SummaryDifference0.0%

Stay in the know with updates to Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.